| Net loss | 3.71M |
| Depreciation and amortization | 4.27M |
| Provision for accounts receivable allowances | 2.55M |
| Deferred tax provision | 799K |
| Loss on sale or disposal of assets | |
| Stock-based compensation expense | 688K |
| Increase in accounts receivable | -48.99M |
| Increase in inventory | -19.82M |
| Increase in other assets | -48K |
| (Decrease) increase in liabilities | |
| Total adjustments | -45.73M |
| Net cash used for operating activities | -42.03M |
| Purchase of property, plant and equipment | -2.83M |
| Proceeds from sale of assets | 311K |
| Net cash used for investing activities | |
| Payments on long-term debt | |
| Borrowings on credit facilities | |
| Repayments on credit facilities | |
| Dividends paid | -3.63M |
| Proceeds from exercise of stock options | |
| Shares withheld for minimum tax withholding on restricted stock | |
| Tax effect on stock awards | 278K |
| Net cash (used for) provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Net decrease in cash and cash equivalents | 10.31M |
| Cash and cash equivalents at beginning of period | 19.93M |
| Cash and cash equivalents at end of period | 30.24M |